Phase II study (KAMELEON) of single-agent T-DM1 in patients with HER2-positive advanced urothelial bladder cancer or pancreatic cancer/cholangiocarcinoma
de Vries, E. G. E., Rüschoff, J., Lolkema, M., Tabernero, J., Gianni, L., Voest, E., . . . Viale, G. … Read More
